Prevalence of bap and ompA immune evasion genes, biofilm formation ability, antibiotic resistance pattern, and motility of Acinetobacter baumannii

Document Type : Research Paper

Authors

1 Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.

2 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Acinetobacter baumannii (A. baumannii) is recognized as a significant pathogen responsible for hospital-acquired infections. This research aims to investigate the frequency of bap and ompA immune evasion genes, thereby determining the profile of antibiotic resistance in bacteria and the biofilm-producing ability among isolates obtained from patients with respiratory infections in Isfahan, Iran. In the present study, among 100 isolates collected from respiratory tract infections, 96 isolates were confirmed as A. baumannii by biochemical tests and molecular analysis. The presence of bap and ompA genes in these isolates was checked by PCR, and antibiotic susceptibility was assessed using the disc diffusion method. Finally, the ability to form biofilm and motility were investigated. Results showed that 100% of the isolates carried the ompA gene. However, for the bap gene, 95.83% of isolates were positive. Investigation of antibiotic resistance showed that A. baumannii isolates exhibited resistance to most antibiotics. The results of the biofilm test revealed that 97.91% of the isolates could form biofilm, including 39.58% with weak biofilm, 44.79% with medium biofilm, and 13.54% with strong biofilm, leaving the remaining 2% unable to form biofilm. Moreover, our results show that 6.4% of isolates were non-motile, 45.9% had an intermediate ability for twitching motility, and 47.7% showed a high ability for twitching motility. No correlation was observed between twitching motility, biofilm production, and antibiotic resistance. The present study demonstrates that the bap and ompA genes are highly abundant in lung infections, and most of these isolates are multidrug-resistant, exhibiting a high ability to form biofilms and display motility.

Keywords

Main Subjects

References

Abdi, S. N., Ghotaslou, R., Ganbarov, K., Mobed, A., Tanomand, A., Yousefi, M., & Kafil, H. S. (2020). Acinetobacter baumannii efflux pumps and antibiotic resistance. Infection and drug resistance, 423-434.‏ https://doi.org/10.2147/IDR.S228089
Ahmad, N. H., & Mohammad, G. A. J. B. S. J. (2020). Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains. 17(3), 0726-0726. https://doi.org/10.21123/bsj.2020.17.3.0726
AShamiri, M. M., Zhang, S., Mi, P., Liu, Y., Xun, M., Yang, E., Chen, Y. (2021). Phenotypic and genotypic characteristics of Acinetobacter baumanniienrolled in the relationship among antibiotic resistance, biofilm formation and motility. Microbial Pathogenesis, 155, 104922. https://doi.org/10.1016/j.micpath.2021.104922
Babapour, E., Haddadi, A., Mirnejad, R., Angaji, S.-A., & Amirmozafari, N. J. A. P. J. o. T. B. (2016). Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. 6(6), 528-533. https://doi.org/10.1016/j.apjtb.2016.04.006
Badmasti, F., Siadat, S. D., Bouzari, S., Ajdary, S., & Shahcheraghi, F. (2015). Molecular detection of genes related to biofilm formation in multidrug-resistant Acinetobacter baumannii isolated from clinical settings. Journal of medical microbiology, 64(Pt_5), 559-564. doi:https://doi.org/10.1099/jmm.0.000058
Chen, W. J. F. i. C., & Microbiology, I. (2020). Host innate immune responses to Acinetobacter baumannii infection. 10, 486. https://doi.org/10.3389/fcimb.2020.00486
De Gregorio, E., Del Franco, M., Martinucci, M., Roscetto, E., Zarrilli, R., & Di Nocera, P. P. J. B. g. (2015). Biofilm-associated proteins: news from Acinetobacter. 16, 1-14. https://doi.org/10.1186/s12864-015-2136-6
Fallah, A., Rezaee, M. A., Hasani, A., Barhaghi, M. H. S., & Kafil, H. S. J. I. j. o. b. m. s. (2017). Frequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation. 20(8), 849. https://doi.org/10.22038/IJBMS.2017.9105
Gedefie, A., Demsis, W., Ashagrie, M., Kassa, Y., Tesfaye, M., Tilahun, M., resistance, d. (2021). Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. 3711-3719. https://doi.org/10.2147/IDR.S332051
Ghadiri, A., Doosti, A., & Shakhsi-Niaei, M. J. I. J. o. M. M. (2023). Prevalence, Antimicrobial Susceptibility, and Distribution of Virulence Genes Involved in Biofilm Formation in Multidrug-Resistant Acinetobacter baumannii Isolated from Shahrekord Medical Centers, Chaharmahal and Bakhtiari, Iran. 17(1), 73-80. http://dx.doi.org/10.30699/ijmm.17.1.73
Goh, H. S., Beatson, S. A., Totsika, M., Moriel, D. G., Phan, M.-D., Szubert, J., microbiology, e. (2013). Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. 79(21), 6535-6543. https://doi.org/10.1128/AEM.01402-13
Harding, C. M., Hennon, S. W., & Feldman, M. F. J. N. R. M. (2018). Uncovering the mechanisms of Acinetobacter baumannii virulence. 16(2), 91-102. https://doi.org/10.1038/nrmicro.2017.148
Liu, C., Liu, J., Lu, Q., Wang, P., & Zou, Q. (2024). The Mechanism of Tigecycline Resistance in Acinetobacter baumannii under Sub-Minimal Inhibitory Concentrations of Tigecycline. International Journal of Molecular Sciences, 25(3), 1819. https://doi.org/10.3390/ijms25031819
Lee, C. R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., & Lee, S. H. (2017). Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Frontiers in cellular and infection microbiology, 7, 55. doi: 10.3389/fcimb.2017.00055
Liu, C., Chang, Y., Xu, Y., Luo, Y., Wu, L., Mei, Z., Jia, X. J. O. (2018). Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates. 9(31), 21663. https://doi.org/10.18632/oncotarget.24651
Monfared, A. M., Rezaei, A., Poursina, F., & Faghri, J. J. A. o. C. I. D. (2019). Detection of genes involved in biofilm formation in MDR and XDR Acinetobacter baumannii isolated from human clinical specimens in Esfahan, Iran. 14(2). https://doi.org/10.5812/archcid.85766
Morris, F. C., Dexter, C., Kostoulias, X., Uddin, M. I., & Peleg, A. Y. J. F. i. m. (2019). The mechanisms of disease caused by Acinetobacter baumannii. 10, 448380. https://doi.org/10.3389/fmicb.2019.01601
Mostafavi, S. N., Rostami, S., Nokhodian, Z., Ataei, B., Cheraghi, A., Ataabadi, P Kelishadi, R. (2021). Antibacterial resistance patterns of Acinetobacter baumannii complex: The results of Isfahan antimicrobial resistance surveillance-1 program. Asian Pacific Journal of Tropical Medicine, 14(7), 316-322. https://doi.org/10.4103/1995-7645.320522
Munier, A.-L., Biard, L., Legrand, M., Rousseau, C., Lafaurie, M., Donay, J.-L., Molina, J.-M. J. I. J. o. I. D. (2019). Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. 79, 179-184. https://doi.org/10.1016/j.ijid.2018.11.371
Nie, D., Hu, Y., Chen, Z., Li, M., Hou, Z., Luo, X., Xue, X. J. J. o. b. s. (2020). Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. 27, 1-8. https://doi.org/10.1186/s12929-020-0617-7
Oh, M. H., Islam, M. M., Kim, N., Choi, C. H., Shin, M., Shin, W. S., & Lee, J. C. (2025). AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA. Journal of Biomedical Science, 32(1), 1-20. https://doi.org/10.1186/s12929-025-01147-5
Pourhajibagher, M., Hashemi, F. B., Pourakbari, B., Aziemzadeh, M., & Bahador, A. (2016). Antimicrobial resistance of Acinetobacter baumannii to imipenem in Iran: a systematic review and meta-analysis. The open microbiology journal, 10, 32. https://doi.org/10.2174/1874285801610010032
Rezaei, A., Fazeli, H., Moghadampour, M., Halaji, M., & Faghri, J. J. I. M. (2018). Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. 26(1), 61-66.
Sadr, M., Fahimzad, S. A., Karimi, A., Fallah, F., Armin, S., Tehrani, N. A., Azimi, L. J. G. R. (2021). Antimicrobial resistance and molecular epidemiology of virulence genes among multi-drug resistant Acinetobacter baumannii clinical isolates in Iran. 24, 101281. https://doi.org/10.1016/j.genrep.2021.101281
Selvaraj, A., Valliammai, A., Sivasankar, C., Suba, M., Sakthivel, G., & Pandian, S. K. (2020). Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii. Scientific reports, 10(1), 21975. https://doi.org/10.1038/s41598-020-79128-x
Shoaib, M., Muzammil, I., Hammad, M., Bhutta, Z. A., & Yaseen, I. J. I. J. o. R. P. (2020). A mini-review on commonly used biochemical tests for identification of bacteria. 54(1), 1-7. https://doi.org/10.47119/IJRP100541620201224
Shokri, D., Rabbani Khorasgani, M., Fatemi, S. M., & Soleimani-Delfan, A. J. J. o. m. m. (2017). Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients. 66(4), 402-411. https://doi.org/10.1099/jmm.0.000444
Stepanović, S., Vuković, D., Dakić, I., Savić, B., & Švabić-Vlahović, M. J. J. o. m. m. (2000). A modified microtiter-plate test for quantification of staphylococcal biofilm formation. 40(2), 175-179. https://doi.org/10.1016/S0167-7012(00)00122-6
Towner, K. J. J. o. H. I. (2009). Acinetobacter: an old friend, but a new enemy. 73(4), 355-363. https://doi.org/10.1016/j.jhin.2009.03.032
Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. J. J. o. c. m. (2006). Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species. 44(8), 2974-2976. https://doi.org/10.1128/jcm.01021-06
 
Microbiology, Metabolites and Biotechnology
Volume 8, Issue 1
June 2025
Pages 1-7

Files

Share

How to cite

Statistics